Last updated on: 17/01/2012
Name of organisation
1) Department/Research groupInnovation Monitoring and Health Technology Assessment
2) Organisation/affiliationGerman Inst. for Medical Documentat. and Informat.
Short Name in the inventoryDIMDI
Administrative Contact
Title Dr
Last name Dauben
First name Hans-Peter
Address line 1Waisenhausgasse 36a-38
Address line 2
Address line 3
CityCologne
Postcode50686
CountryGermany
Phone number (incl. country code)49-221-4724311
Alternative phone number49-221-4724212
Fax number (incl. country code)49-221-4724440
Scientific Contact
Title Dr
Last name Dauben
First name Hans-Peter
Address line 1Waisenhausgasse 36a-38
Address line 2
Address line 3
CityCologne
Postcode50686
CountryGermany
Phone number (incl. country code)49-221-4724311
Alternative phone number49-221-4724212
Fax number (incl. country code)49-221-4724440
2. Description
DIMDI (German Institute for Medical Documentation and Information) is an institute within the scope of the ministry of health and dealing with different kind of information on pharmaceuticals and medical devices. We are offering services to the public related to medical knowledge management and are the host of the German Agency for Health technology assessment (DAHTA) as well as the secretariat of the International network of HTA agencies and founding member of the European netowrk of HTA agencies (EUnetHTA). We are also listed as NCA within the EMA and are represented in some TIGs. Our work is very much bridging the area of knowledge and IT related services. We also host the national register of medical devices and pharmaceutical products.
In relation to innovation monitoring and HTA and as member of the network EuroScan international we are very much interested in getting better data on daily life data and are doing this in connection and cooperation with our sister institute BfArM.
3. Category
Government based
4. Available resources
In houseVia Contacts/Network
Epidemiologist/Pharmacoepidemiologist
Yes
Yes
Statistician
No
Yes
Clinician
Yes
Yes
Clinical Pharmacologist
Yes
Yes
Pharmacist
Yes
Yes
Geneticist/Pharmacogeneticist
No
Yes
IT specialist
Yes
No
Ethics expertise
No
Yes
Legal expertise
Yes
No
Regulatory expertise
Yes
No
evidence based medicine experts
Yes
Yes
classification and nomenclation experts
Yes
Yes
medical device and pharmaceutical experts
Yes
Yes
5. Therapeutic/disease areas of research in drug safety/risk-benefit performed in the past 5 years
Cardiovascular diseases
Congenital Malformations
Devices
Disorders of the central nervous system
Ear, nose and oropharynx disorders
Endocrine disorders
Gastrointestinal tract
Gynaecology
Immunological products and vaccines
Infectious diseases
Liver disease
Malignant disease
Musculoskeletal and joint diseases
Neonates
Osteoporosis
Paediatrics
Pregnancy
Psychiatry
Respiratory diseases
Skin disorders
6. Design of drug safety/risk-benefit studies published in the past 5 years
Meta-Analysis
Health Technology Assessment
7. Experience in collecting data directly from individual patients/respondents
None
8. Access to data collection resources
Capacity to conduct face-to-face interviews
No
Electronic data capture systems
Yes
System used:
generic DIMDI system
Interactive voice response systems
No
Call centre
No
9. Experience in secondary research and meta-analysis
Yes
10. Work with existing data resources in the past 3 years
Name of data resourceNo. of studies
AMIS/PharmNet100
DIMDI (public- ebm databases)150
DIMDI (confidential-national register)150
11. Registries established by centre
Drug RegistryNational register of drugs
Other national register of medical devices
12. Experience in collaboration in a study team
Principal Investigator
Collaborating Investigator
13. Current involvement in research networks
Other networks:
Network nameNationalInternationalLink to webpage
14. Interest in research opportunities which are funded
By pharmaceutical companies
By charities
By government
By research councils
By EU funding schemes
15. Interest in contract research only if free to publish results
Yes
16. Selected publications of the last 5 calendar years
ReferenceLink to web-publication
